Sorry, you need to enable JavaScript to visit this website.
  1. Home
  3. Science
  4. Clinical Trials
  5. Plain Language Study Results Summaries
  6. Clinical Trial Brentuximab Vedotin

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

Category & Conditions: Cancer
Medicine: ADCETRIS®(BRENTUXIMAB VEDOTIN)
ClinicalTrials.gov Identifier (NCT): NCT03646123
Protocol ID: C5691002
DownloadPrint

Open Plain Language Summary Result:

Click here